[1]孔令军,何海龙.不同方法治疗重型再生障碍性贫血儿童临床不良反应分析[J].医学信息,2018,31(24):59-62.[doi:10.3969/j.issn.1006-1959.2018.24.015]
　KONG Ling-jun,HE Hai-long.Analysis of Clinical Adverse Reactions in Children with Severe Aplastic Anemia Treated by Different Methods[J].Journal of Medical Information,2018,31(24):59-62.[doi:10.3969/j.issn.1006-1959.2018.24.015]
点击复制

不同方法治疗重型再生障碍性贫血儿童临床不良反应分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年24期
页码:
59-62
栏目:
论著
出版日期:
2018-12-15

文章信息/Info

Title:
Analysis of Clinical Adverse Reactions in Children with Severe Aplastic Anemia Treated by Different Methods
文章编号:
1006-1959（2018）24-0059-04
作者:
孔令军; 何海龙
苏州大学附属儿童医院血液科，江苏 苏州 215003
Author(s):
KONG Ling-jun; HE Hai-long
Department of Hematology,Children's Hospital Affiliated to Suzhou University,Suzhou 215003,Jiangsu,China
关键词:
造血干细胞移植; 免疫抑制治疗; 移植物抗宿主病; 血清病样反应; 再生障碍性贫血
Keywords:
Hematopoiet·ic stem cell transplantation; Immunosuppressive therapy; Graft versus host disease; Serum-like reaction; Aplastic anemia
分类号:
R556
DOI:
10.3969/j.issn.1006-1959.2018.24.015
文献标志码:
A
摘要:
目的 探讨HSCT和IST治疗儿童重型再生障碍性贫血的不良反应。方法 回顾性分析2011年10月~2017年11月我院收治的113例SAA及vSAA患儿的临床资料，其中接受HSCT治疗的30例设为HSCT组，接受IST治疗的83例设为IST组，比较两组不良反应发生率，HSCT组内不同供体状态不良反应发生率、IST组内应用p-ALG与r-ATG不良反应发生率。结果 治疗后HSCT组感染发生率（60.00%）总体较IST组（35.92%）高（P＜0.05）；其中HSCT组疱疹病毒感染发生率（23.33%）较IST组（3.61%）高（P＜0.05）；两组脓毒血症、肺部感染及真菌感染发生率比较差异无统计学意义（P＞0.05）；HSCT组中，非MSD治疗与MSD治疗其Ⅰ度aGVHD发生率比较，差异无统计学意义（P＞0.05）； 非MSD治疗较MSD治疗发生Ⅱ度及以上aGVHD、cGVHD的发生率高（P＜0.05）；药物应用时主要不良反应为类过敏反应，r-ATG发生率高于p-ALG（P＜0.05）；药物应用后主要不良反应为血清病样反应，两种药物发生率比较，差异无统计学意义（P＞0.05）。结论 感染是SAA治疗中最常见不良反应，HSCT组更易发生，尤其是疱疹病毒感染比例高；HSCT治疗应注意供体选择，减少GVHD发生率；IST组应用r-ATG更易出现类过敏反应，需引起重视。
Abstract:
Objective To investigate the adverse reactions of HSCT and IST in the treatment of severe aplastic anemia in children. Methods The clinical data of 113 children with SAA and vSAA admitted to our hospital from October 2011 to November 2017 were retrospectively analyzed. Among them, 30 patients receiving HSCT were assigned to HSCT group, and 83 patients receiving IST treatment were set as IST group. The incidence of adverse reactions in the two groups was compared, the incidence of adverse reactions in different donor states in the HSCT group, and the incidence of adverse reactions in the IST group using p-ALG and r-ATG. Results The incidence of infection in HSCT group after treatment (60.00%) was higher than that in IST group (35.92%) (P<0.05). The incidence of herpesvirus infection in HSCT group (23.33%) was higher than that in IST group (3.61%) (P<0.05). There was no significant difference in the incidence of sepsis, pulmonary infection and fungal infection between the two groups (P>0.05).There was no significant difference in the incidence of grade I aGVHD between the non-MSD group and the MSD group in the HSCT group (P>0.05). The incidence of aGVHD and cGVHD was higher in the non-MSD treatment than in the MSD treatment (P<0.05); the main adverse reactions in drug application were allergic reactions, the incidence of r-ATG was higher than that of p-ALG (P<0.05); the main adverse reaction after drug application was serum-like reaction, the incidence of the two drugs was compared, the difference was not statistically significant (P>0.05). Conclusion Infection is the most common adverse reaction in SAA treatment, HSCT group is more likely to occur, especially herpes virus infection rate; HSCT treatment should pay attention to donor selection, reduce the incidence of GVHD; IST group is more prone to allergic reactions using r-ATG, need to cause pay attention to it.

参考文献/References:

[1]Boddu PC,Kadia TM.Updates on the pathophysiology and treatment of aplastic anemia:a comprehensive review[J].Expert Review of Hematology,2017,10(5):433-438.
[2]Barone A,Lucarelli A,Onofrillo D,et a1.Diagnosis and management of acquired aplastic anemia in childhood.Guidelines from the Marrow Failure Study Group of the Pediateic Haemato Oncology Italian Association(AIEOP)[J].Blood Cells Mol Dis,2015,55(1):40-47.
[3]中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会.儿童获得性再生障碍性贫血诊疗建议[J].中华儿科杂志,2014,52(2):103-106．
[4]Killick SB,Bown N,Cavenagh J,et a1.Guidelines for the diagnosis and management of adult aplastic anaemia[J].Br J Haemat,2016,172(2):187-207.
[5]中华医学会血液学分会红细胞疾病(贫血)学组.再生障碍性贫血诊断与治疗中国专家共识(2017年版)[J].中华血液学杂志,2017,38(1):1-5.
[6]陶晓虹,董红华.再生障碍性贫血患者医院感染相关因素分析与预防[J].中华医院感染学杂志,2016,26 (5):1020-1030.
[7]中华医学会血液学分会.中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2016年版)[J].中华血液学杂志,2016, 37(5):353-359.
[8]Dufour C,Pillon M,Passweg J,et al.Outcome of aplastic anemia in adolescence:a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation[J].Haematologica,2015,169(4):565-573.
[9]苏雁,吴润晖,马洁,等.兔抗胸腺细胞球蛋白联合环孢素免疫抑制治疗儿童重型再生障碍性贫血的疗[J].中华实用儿科临床杂志,2015,30(3):189-193.
[10]杨楠,马肖容,张卉,等.猪抗人淋巴细胞球蛋白与兔抗人胸腺细胞球蛋白治疗重型再生障碍性贫血的疗效比较[J].南方医科大学学报,2016,36(3):303-308.

相似文献/References:

[1]彭裕连,谷加丽,王玉蕾,等.慢性肉芽肿病临床特点及预后分析[J].医学信息,2020,33(01):190.[doi:10.3969/j.issn.1006-1959.2020.01.064]
　PENG Yu-lian,GU Jia-li,WANG Yu-lei,et al.Clinical Characteristics and Prognosis of Chronic Granulomatous Disease[J].Journal of Medical Information,2020,33(24):190.[doi:10.3969/j.issn.1006-1959.2020.01.064]
[2]肖 莉,宋 萍.造血干细胞移植的手术编码探讨及案例分析[J].医学信息,2020,33(20):1.[doi:10.3969/j.issn.1006-1959.2020.20.001]
　XIAO Li,SONG Ping.Discussion and Case Analysis of Surgical Coding for Hematopoietic Stem Cell Transplantation[J].Journal of Medical Information,2020,33(24):1.[doi:10.3969/j.issn.1006-1959.2020.20.001]
[3]金秋颖.幼年型粒单核细胞白血病的发病机制及诊治[J].医学信息,2020,33(21):51.[doi:10.3969/j.issn.1006-1959.2020.21.015]
　JIN Qiu-ying.Pathogenesis, Diagnosis and Treatment of Juvenile Myelomonocytic Leukemia[J].Journal of Medical Information,2020,33(24):51.[doi:10.3969/j.issn.1006-1959.2020.21.015]
[4]邓 慧,侯著法,刘松山.肝脾T细胞淋巴瘤1例报告并文献复习[J].医学信息,2021,34(09):191.[doi:10.3969/j.issn.1006-1959.2021.09.053]
[5]刘晓霞,陈晓宇.营养支持治疗对造血干细胞移植患者营养状态影响的研究进展[J].医学信息,2023,36(14):188.[doi:10.3969/j.issn.1006-1959.2023.14.041]
　LIU Xiao-xia,CHEN Xiao-yu.Research Progress on the Effect of Nutritional Support Therapy on Nutritional Status of Patients with Hematopoietic Stem Cell Transplantation[J].Journal of Medical Information,2023,36(24):188.[doi:10.3969/j.issn.1006-1959.2023.14.041]
[6]石 莹,高 丽,于俊叶,等.净化舱内造血干细胞移植患者不同治疗阶段心理体验及支持需求质性研究的Meta整合[J].医学信息,2023,36(17):15.[doi:10.3969/j.issn.1006-1959.2023.17.003]
　SHI Ying,GAO Li,YU Jun-ye,et al.Meta- synthesis of Qualitative Research on Psychological Experience and Support Needs of Patients with Hematopoietic Stem Cell Transplantation in Purified Cabin at Different Treatment Stages[J].Journal of Medical Information,2023,36(24):15.[doi:10.3969/j.issn.1006-1959.2023.17.003]

更新日期/Last Update: 2019-01-09